
Pharmacists can assess tolerability and identify OTC or compounded products patients may be taking alongside therapy, according to Biykem Bozkurt, MD, PhD.

Biykem Bozkurt, MD, PhD, is a professor of medicine and senior dean at Baylor College of Medicine.

Pharmacists can assess tolerability and identify OTC or compounded products patients may be taking alongside therapy, according to Biykem Bozkurt, MD, PhD.

Pharmacists can assess tolerability and identify OTC or compounded products patients may be taking alongside therapy, according to Biykem Bozkurt, MD, PhD.

Survodutide met noninferiority for 5-point MACE, supporting its safety in adults with obesity and established CV disease or elevated risk.

Biykem Bozkurt, MD, PhD, explains why survodutide's glucagon component called for a dedicated noninferiority trial in adults with obesity.

Biykem Bozkurt, MD, PhD, FACC, highlights the need for reliable activity monitoring in heart failure care, addressing challenges of digital wearables in clinical practice.

Discover how objective activity monitoring with accelerometers transforms cardiovascular risk assessment and treatment evaluation, enhancing patient care for pharmacists.

A new wrist-worn accelerometer device effectively monitors activity levels in heart failure patients, revealing critical insights into cardiovascular health.

November 12th 2025

November 10th 2026